General Information of Drug (ID: DM04U2E)

Drug Name
NCI-4650
Indication
Disease Entry ICD 11 Status REF
Melanoma 2C30 Phase 1/2 [1]
Cross-matching ID
TTD ID
D07YNC

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)